Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / The Baby Steps of Infant Immunity
Translational Science Translational Science News and Research

The Baby Steps of Infant Immunity

LC-MS profiling shows rapid establishment of systemic immunity in infants 

03/04/2026 1 min read

Share

Newborns begin producing their own antibodies within weeks of birth, rather than relying solely on maternal immunity for months, according to a study that disentangles infant- and mother-derived antibody repertoires with clonal precision. 

The study applied intact LC-MS-based Fab profiling to compare IgA1 and IgG1 antibody repertoires across matched maternal serum, breast milk, and infant serum samples. By resolving antibodies at the clonal level, the approach allowed the team to track which antibodies persisted from the mother and which emerged de novo in the infant. 

The researchers analyzed samples from four mother–infant pairs collected at birth and again 7–11 weeks postpartum. At birth, infant serum was dominated by maternal IgG1 – transferred across the placenta – while IgA1 was nearly absent. By the second timepoint, however, the antibody landscape had changed markedly. Clonal profiling showed that infant serum contained IgA1 and IgG1 antibodies that did not overlap with maternal serum or breast milk, indicating de novo antibody production by the infant. 

For IgA1, clonal repertoire analysis showed that infant serum contained entirely new antibody clones that did not overlap with maternal serum or breast milk. This indicates that IgA1 detected in infant circulation at this stage is produced by the infant, rather than absorbed from milk. Similar patterns emerged for IgG1: although maternal IgG1 dominated infant serum at birth, a substantial fraction of new, infant-specific IgG1 clones appeared within the first two to three months of life. 

Notably, the analysis found no convincing evidence that IgA antibodies from breast milk enter the infant bloodstream, challenging a common assumption about maternal antibody transfer. Instead, the data support a model in which milk IgA primarily acts at mucosal surfaces, while systemic humoral immunity is established rapidly by the infant. 

The results suggest that infant antibody production begins earlier than commonly assumed, with implications for neonatal immune development and vaccination strategies. The authors note that MS-based clonal profiling provides a direct way to track these dynamics across maternal and infant compartments. 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #5
Translational Science
The Analytical Scientist Innovation Awards 2024: #5

December 4, 2024

4 min read

Welcome to the 5th ranked Innovation, Pyxis – introduced here by Matterworks co-founder Jack Geremia

The Analytical Scientist Innovation Awards 2024: #4
Translational Science
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

The Analytical Scientist Innovation Awards 2024: #3
Translational Science
The Analytical Scientist Innovation Awards 2024: #3

December 6, 2024

4 min read

Bruker’s multiphoton microscopy module, OptoVolt, ranks third in our Innovation Awards. Here, Jimmy Fong, product development lead, walks us through the major moments during development.

Spit It Out
Translational Science
Spit It Out

December 4, 2024

1 min read

Saliva-based PA-MS test detects paracetamol overdose in just 10 minutes

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.